iles
| Species | Cat.# | Product name | Source (Host) | Tag | Protein Length | Price |
|---|---|---|---|---|---|---|
| Bacillus subtilis | ILES-2341B | Recombinant Bacillus subtilis ILES protein, His-tagged | E. coli or Yeast | His |
|
|
| Staphylococcus | ILES-1384S | Recombinant Staphylococcus aureus ILES protein, His-tagged | E. coli or Yeast | His |
|
|
| Staphylococcus | ILES-1313S | Recombinant Staphylococcus epidermidis ATCC 12228 ILES protein, His-tagged | E. coli or Yeast | His |
|
|
| Staphylococcus | ILES-3612S | Recombinant Staphylococcus aureus subsp. aureus NCTC 8325 ILES protein, His-tagged | E. coli or Yeast | His |
|
|
| Streptomyces coelicolor A3(2) | ILES-1277S | Recombinant Streptomyces coelicolor A3(2) ILES protein, His-tagged | E. coli or Yeast | His |
|
- Q&As
- Reviews
Q&As (6)
Ask a questionILES is one of the latest biotherapy, compared to conventional radiotherapy, and chemotherapy have fewer side effects, but the treatment effect and efficacy duration may be different.
The effectiveness of ILES therapy can be measured by monitoring indicators such as tumor size, changes in patient symptoms, and immune system response.
The use of ILES may cause adverse effects such as fever, headache, fatigue, muscle and joint pain, but most patients can tolerate them.
ILES is usually administered intravenously, and the dose and treatment period will vary from individual to individual.
The ILES is mainly used to treat breast cancer, but it can also be used in other types of tumors.
This protein can activate the body's immune system, prompting immune cells to attack and kill cancer tissue.
Customer Reviews (3)
Write a reviewShort half-life, more flexible dosage plan.
The results of ILES experiment are highly reproducible.
It is easy to use and requires little preparation before the experiment.
Ask a Question for All iles Products
Required fields are marked with *
My Review for All iles Products
Required fields are marked with *
